Whipple Procedure: A 5-year Clinical Experience in Tertiary Care Center
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03820583 |
Recruitment Status :
Completed
First Posted : January 29, 2019
Last Update Posted : January 31, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Whipple Procedure | Procedure: Whipple Procedure | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 57 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Intervention Model Description: | Patients undergoing Whipple procedure due to pancreatic tumor were included in the study |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Whipple Procedure: A 5-year Clinical Experience in Tertiary Care Center |
Actual Study Start Date : | January 1, 2014 |
Actual Primary Completion Date : | December 31, 2018 |
Actual Study Completion Date : | December 31, 2018 |

- Procedure: Whipple Procedure
Patients underwent Whipple procedure for pancreatic tumors. The procedure commenced with rooftop incision. then layers of abdomen dissected to reach the peritoneum. Then Duodenum dissected out along with pancreas and common bile duct. After rescetion of these structures the anatomy of the tract restored with three anastomosis namely pancreaticojejunostomy, gastrojejunostomy and choledochojejunostomy/hepaticojejunostomy.
- Percentage of patients developing pancreatic fistula [ Time Frame: 4 weeks ]Percentage of patients developing pancreatic fistula (pancreatic juice collected in drain rich in amylase) after Whipple procedure Enteric leak postoperative complications like pancreatic fistula, anastomotic leakage, hemorrhage, wound infection,mortality
- Percentage of patients developing hemorrhage [ Time Frame: 2 weeks ]Percentage of patients developing hemorrhage after Whipple procedure
- Percentage of patients developing wound infection [ Time Frame: 4 weeks ]Percentage of patients developing wound infection after Whipple procedure
- Mortality rate [ Time Frame: 6 weeks ]Mortality of patients undergoing Whipple surgery

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 20 Years to 70 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- patients of both sexes with age ranging from 20 years to 70 years
- patients with pancreatic tumors
- patients with adequate cardiorespiratory reserves to be fit for prolong general anesthesia
Exclusion Criteria:
- unresectable tumors
- unfit for surgery

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03820583
Pakistan | |
Services hospital | |
Lahore, Punjab, Pakistan, 54000 |
Study Director: | Mahmmood Ayyaz, mbbs, fcps | Services Hospital, Lahore |
Responsible Party: | Dr. SamiUllah, Principle investigator, Services Hospital, Lahore |
ClinicalTrials.gov Identifier: | NCT03820583 |
Other Study ID Numbers: |
s11 |
First Posted: | January 29, 2019 Key Record Dates |
Last Update Posted: | January 31, 2019 |
Last Verified: | January 2019 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Whipple procedure, pancreatic carcinoma, biliary stenting, |